AngioDynamics Gross Profit from 2010 to 2025

ANGO Stock

USD 9.92 0.05 0.51%

AngioDynamics Gross Profit yearly trend continues to be very stable with very little volatility. Gross Profit is likely to drop to about 131.3 M. Gross Profit is the profit AngioDynamics makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals

Gross Profit

First Reported

2001-08-31

Previous Quarter

36.7 M

Current Value

39.9 M

Quarterly Volatility

15.1 M

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check AngioDynamics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AngioDynamics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 18.5 M, Interest Expense of 1.7 M or Total Revenue of 246.7 M, as well as many indicators such as Price To Sales Ratio of 0.91, Dividend Yield of 0.0 or PTB Ratio of 1.17. AngioDynamics financial statements analysis is a perfect complement when working with AngioDynamics Valuation or Volatility modules.

Check out the analysis of AngioDynamics Correlation against competitors.

To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.

Latest AngioDynamics' Gross Profit Growth Pattern

Below is the plot of the Gross Profit of AngioDynamics over the last few years. Gross profit is a required income statement account that reflects total revenue of AngioDynamics minus its cost of goods sold. It is profit before AngioDynamics operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. AngioDynamics' Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AngioDynamics' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 151.01 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Gross Profit

Timeline

AngioDynamics Gross Profit Regression Statistics

	Arithmetic Mean	155,781,695
	Geometric Mean	138,811,896
	Coefficient Of Variation	27.29
	Mean Deviation	25,711,756
	Median	173,969,000
	Standard Deviation	42,515,402
	Sample Variance	1807.6T
	Range	180.9M
	R-Value	0.34
	Mean Square Error	1716.8T
	R-Squared	0.11
	Significance	0.20
	Slope	3,008,799
	Total Sum of Squares	27113.4T

AngioDynamics Gross Profit History

	2025	131.3 M
	2024	177.9 M
	2023	154.7 M
	2022	174.2 M
	2021	165.7 M
	2020	156.8 M
	2019	150.3 M

Other Fundumenentals of AngioDynamics

Gross Profit Margin

AngioDynamics Gross Profit component correlations

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Short Term Investments	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Good Will	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Treasury Stock	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.99	0.46	0.48	0.57	0.03	0.78	0.68	0.2	0.92	0.48	0.64	0.86	0.54	0.6	0.76	-0.49	0.3	-0.35	0.04	0.14	-0.02	0.42	0.26	-0.38
Total Stockholder Equity	0.99		0.53	0.4	0.55	0.0	0.69	0.62	0.19	0.84	0.48	0.55	0.85	0.54	0.52	0.74	-0.48	0.21	-0.32	0.13	0.03	-0.11	0.37	0.29	-0.39
Current Deferred Revenue	0.46	0.53		0.13	0.67	-0.66	0.21	-0.11	-0.04	0.24	0.14	0.13	0.36	0.02	-0.2	0.68	-0.67	0.17	-0.43	0.34	-0.13	-0.16	0.56	0.4	-0.59
Net Debt	0.48	0.4	0.13		0.66	-0.27	0.64	0.4	0.48	0.62	-0.4	0.68	0.51	-0.1	0.59	0.7	-0.7	0.63	-0.73	-0.5	0.8	0.6	0.48	-0.46	-0.51
Retained Earnings	0.57	0.55	0.67	0.66		-0.69	0.6	0.03	0.3	0.54	-0.11	0.54	0.43	-0.26	0.06	0.94	-0.89	0.72	-0.85	-0.29	0.54	0.46	0.77	0.22	-0.76
Accounts Payable	0.03	0.0	-0.66	-0.27	-0.69		0.04	0.55	0.01	0.11	0.45	-0.12	0.02	0.55	0.46	-0.55	0.76	-0.35	0.66	-0.05	-0.29	-0.21	-0.52	-0.08	0.68
Long Term Debt	0.78	0.69	0.21	0.64	0.6	0.04		0.6	0.45	0.9	0.36	0.7	0.54	0.23	0.61	0.69	-0.42	0.75	-0.51	-0.42	0.55	0.38	0.7	0.24	-0.29
Net Receivables	0.68	0.62	-0.11	0.4	0.03	0.55	0.6		0.17	0.76	0.49	0.59	0.6	0.75	0.88	0.3	-0.03	0.03	0.11	-0.07	0.12	-0.11	-0.06	-0.08	0.06
Short Term Investments	0.2	0.19	-0.04	0.48	0.3	0.01	0.45	0.17		0.22	-0.1	0.04	0.08	-0.05	0.3	0.25	-0.2	0.42	-0.42	-0.43	0.46	0.54	0.26	-0.18	-0.19
Total Liab	0.92	0.84	0.24	0.62	0.54	0.11	0.9	0.76	0.22		0.42	0.79	0.8	0.47	0.74	0.72	-0.46	0.48	-0.38	-0.2	0.39	0.2	0.49	0.17	-0.31
Total Current Assets	0.48	0.48	0.14	-0.4	-0.11	0.45	0.36	0.49	-0.1	0.42		0.09	0.25	0.71	0.22	0.03	0.28	-0.13	0.42	0.27	-0.43	-0.45	0.03	0.74	0.24
Short Term Debt	0.64	0.55	0.13	0.68	0.54	-0.12	0.7	0.59	0.04	0.79	0.09		0.5	0.16	0.52	0.69	-0.47	0.52	-0.46	-0.14	0.54	0.17	0.47	-0.01	-0.39
Intangible Assets	0.86	0.85	0.36	0.51	0.43	0.02	0.54	0.6	0.08	0.8	0.25	0.5		0.54	0.62	0.61	-0.55	0.07	-0.28	0.07	0.16	0.02	0.2	-0.01	-0.35
Common Stock	0.54	0.54	0.02	-0.1	-0.26	0.55	0.23	0.75	-0.05	0.47	0.71	0.16	0.54		0.63	0.03	0.19	-0.47	0.51	0.43	-0.43	-0.53	-0.31	0.11	0.27
Property Plant Equipment	0.6	0.52	-0.2	0.59	0.06	0.46	0.61	0.88	0.3	0.74	0.22	0.52	0.62	0.63		0.31	-0.14	0.12	-0.03	-0.22	0.29	0.16	-0.01	-0.35	0.04
Good Will	0.76	0.74	0.68	0.7	0.94	-0.55	0.69	0.3	0.25	0.72	0.03	0.69	0.61	0.03	0.31		-0.87	0.6	-0.76	-0.13	0.43	0.28	0.69	0.16	-0.75
Net Tangible Assets	-0.49	-0.48	-0.67	-0.7	-0.89	0.76	-0.42	-0.03	-0.2	-0.46	0.28	-0.47	-0.55	0.19	-0.14	-0.87		-0.49	0.81	0.14	-0.51	-0.39	-0.6	0.04	0.79
Long Term Debt Total	0.3	0.21	0.17	0.63	0.72	-0.35	0.75	0.03	0.42	0.48	-0.13	0.52	0.07	-0.47	0.12	0.6	-0.49		-0.77	-0.69	0.8	0.71	0.85	0.17	-0.42
Capital Surpluse	-0.35	-0.32	-0.43	-0.73	-0.85	0.66	-0.51	0.11	-0.42	-0.38	0.42	-0.46	-0.28	0.51	-0.03	-0.76	0.81	-0.77		0.44	-0.68	-0.64	-0.72	0.05	0.84
Deferred Long Term Liab	0.04	0.13	0.34	-0.5	-0.29	-0.05	-0.42	-0.07	-0.43	-0.2	0.27	-0.14	0.07	0.43	-0.22	-0.13	0.14	-0.69	0.44		-0.74	-0.78	-0.29	0.13	0.14
Treasury Stock	0.14	0.03	-0.13	0.8	0.54	-0.29	0.55	0.12	0.46	0.39	-0.43	0.54	0.16	-0.43	0.29	0.43	-0.51	0.8	-0.68	-0.74		0.76	0.54	-0.29	-0.31
Short Long Term Debt	-0.02	-0.11	-0.16	0.6	0.46	-0.21	0.38	-0.11	0.54	0.2	-0.45	0.17	0.02	-0.53	0.16	0.28	-0.39	0.71	-0.64	-0.78	0.76		0.41	-0.22	-0.31
Net Invested Capital	0.42	0.37	0.56	0.48	0.77	-0.52	0.7	-0.06	0.26	0.49	0.03	0.47	0.2	-0.31	-0.01	0.69	-0.6	0.85	-0.72	-0.29	0.54	0.41		0.36	-0.47
Net Working Capital	0.26	0.29	0.4	-0.46	0.22	-0.08	0.24	-0.08	-0.18	0.17	0.74	-0.01	-0.01	0.11	-0.35	0.16	0.04	0.17	0.05	0.13	-0.29	-0.22	0.36		-0.09
Capital Stock	-0.38	-0.39	-0.59	-0.51	-0.76	0.68	-0.29	0.06	-0.19	-0.31	0.24	-0.39	-0.35	0.27	0.04	-0.75	0.79	-0.42	0.84	0.14	-0.31	-0.31	-0.47	-0.09

Click cells to compare fundamentals

About AngioDynamics Financial Statements

AngioDynamics investors utilize fundamental indicators, such as Gross Profit, to predict how AngioDynamics Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.

	Last Reported	Projected for Next Year
Gross Profit	177.9 M	131.3 M
Gross Profit Margin	0.51	0.59

When determining whether AngioDynamics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AngioDynamics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Angiodynamics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Angiodynamics Stock:

How To Invest In AngioDynamics

Details

Is AngioDynamics Stock a good investment?

Details

What is AngioDynamics' Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out the analysis of AngioDynamics Correlation against competitors.

To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.

You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AngioDynamics. If investors know AngioDynamics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AngioDynamics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(5.59)

Revenue Per Share

7.064

Quarterly Revenue Growth

(0.08)

Return On Assets

(0.06)

Return On Equity

(0.76)

The market value of AngioDynamics is measured differently than its book value, which is the value of AngioDynamics that is recorded on the company's balance sheet. Investors also form their own opinion of AngioDynamics' value that differs from its market value or its book value, called intrinsic value, which is AngioDynamics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AngioDynamics' market value can be influenced by many factors that don't directly affect AngioDynamics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between AngioDynamics' value and its price as these two are different measures arrived at by different means. Investors typically determine if AngioDynamics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AngioDynamics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

AngioDynamics Gross Profit from 2010 to 2025

Latest AngioDynamics' Gross Profit Growth Pattern

AngioDynamics Gross Profit Regression Statistics

AngioDynamics Gross Profit History

Other Fundumenentals of AngioDynamics

AngioDynamics Gross Profit component correlations

About AngioDynamics Financial Statements

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY